|
1
2023
|
1
Saira Naseem,,''Therapeutic potential of 1,3,4-oxadiazoles as potential lead compounds for the treatment of Alzheimer's disease'',Royal society of chemistry ,2023.
|
|
2
2023
|
2
Rabia Basri,,''2-Oxoquinoline-based-thiosemicarbazones as multitargeting neurotherapeutics against Alzheimer's disease: In vitro and in silico studies of MAO and ChE inhibitors'',Arch. Pharm ,2023.
|
|
3
2023
|
3
Faiza Seraj,,''Evaluation of synthetic aminoquinoline derivatives as urease inhibitors: in vitro, in silico and kinetic studies'',,2023.
|
|
4
2022
|
4
Ayesha Naseer,Faisal Abdulrhman Osra,Asia Naz Awan''Exploring Novel Pyridine Carboxamide Derivatives as Urease Inhibitors: Synthesis, Molecular Docking, Kinetic Studies and ADME Profile'',Pharmaceuticals ,2022.
|
|
5
2022
|
5
Aqeel Imran ,,''Development and exploration of novel substituted thiosemicarbazones as inhibitors of aldose reductase via in vitro analysis and computational study'',Scientific Reports ,2022.
|
|
6
2022
|
6
Syeda Uroos qazi ,,''Urease inhibitory kinetics, molecular docking, SAR and ADME studies of imine analogues'',New Journal of Chemistry,2022.
|
|
7
2021
|
7
Muhammad Tariq Shehzad,,''synthesis of indole substituted thiosemicarbazones as an aldose reductase inhibitor: an in vitro, selectivity and in silico study'',Future Medicinal Chemistry,2021.
|
|
8
2021
|
8
Mohsinul Mulk Bacha,,''Rhodanine-3-acetamide derivatives as aldose and aldehyde reductase inhibitors to treat diabetic complications: synthesis, biological evaluation, molecular docking and simulation studies'',BMC Chemistry ,2021.
|
|
9
2021
|
9
Mark Laws,,''Current Trends and Future Approaches in Small-Molecule Therapeutics for COVID-19'',Current Medicinal Chemistry,2021.
|
|
10
2021
|
10
Aqeel Imran ,,''Development of Coumarin-Thiosemicarbazone Hybrids as Aldose Reductase Inhibitors: Biological Assays, Molecular docking, Simulation studies and ADME Evaluation'',Bioorganic Chemistry,2021.
|
|
11
2021
|
11
Muhammad Tariq Shehzad ,,''Exploring Synthetic and Therapeutic Prospects of New Thiazoline Derivatives as Aldose Reductase (ALR2) Inhibitors'',RSC Advances ,2021.
|
|
12
2020
|
12
Asad Hamad ,,''Probing sulphamethazine and sulphamethoxazole based Schiff bases as urease inhibitors; synthesis, characterization, molecular docking and ADME evaluation'',Bioorganic Chemistry,2020.
|
|
13
2019
|
13
Muhammad Tariq Shehzad,,''Exploring antidiabetic potential of adamantyl-thiosemicarbazones via aldose reductase (ALR2) inhibition'',Bioorganic Chemistry,2019.
|
|
14
2014
|
14
Aamer Saeed,,''"2-(Hetero (aryl) methylene) hydrazine-1-carbothioamides as Potent Urease Inhibitors."'',Chemical biology and drug design ,2014.
|
|
15
|
15
Aqeel Imran ,,''Development, Molecular Docking, and In Silico ADME Evaluation of Selective ALR2 Inhibitors for the Treatment of Diabetic Complications via Suppression of the Polyol Pathway'',ACS Omega ,.
|
|
16
|
16
Noman Javid,,''Exploiting oxadiazole-sulfonamide hybrids as new structural leads to combat diabetic complications via aldose reductase inhibition'',Bioorganic chemistry,.
|
|
17
|
17
Muhammad Tariq Shehzad ,,''Benzoxazinone-thiosemicarbazones as antidiabetic leads via aldose reductase inhibition: Synthesis, biological screening and molecular docking study'',Bioorganic chemistry ,.
|